#Moca electronic cognitive assessment update#

HIV associated neurocognitive disorders in the modern antiviral treatment era: Prevalence, characteristics, biomarkers, and effects of treatment. International Journal of Geriatric Psychiatry, 33(2), 379–388.Ĭhan, P., & Brew, B. A re-examination of Montreal cognitive assessment (MoCA) cutoff scores. Journal of the Neurological Sciences, 260(1–2), 11–15.Ĭarson, N., Leach, L., & Murphy, K. The HIV dementia scale: Predictive power in mild dementia and HAART. Applied Neuropsychology: Adult, 20(1), 33–40.īottiggi, K. Validity of the Montreal cognitive assessment in the detection of cognitive dysfunction in Huntington's disease. Updated research nosology for HIV-associated neurocognitive disorders. Accessed 12 January 2019.Īntinori, A., Arendt, G., Becker, J. BHIVA guidelines for the routine investigation and monitoring of adult HIV-1-positive individuals. Clinical Infectious Diseases, 58(1), e1–e34.Īngus, B., Awosusi, F., Barker, G., Boffito, M., Brook, G., Das, S., et al.

#Moca electronic cognitive assessment update#

Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine Association of the Infectious Diseases Society of America. Nonetheless, the choice of cut-off always comes with a sensitivity-specificity trade-off, the preferred cut point depending on whether sensitivity or specificity is more valuable in a given context.Īberg, J. A lower threshold than the original cut-off of 26 is probably more useful for optimal screening of HAND, as it lowers false positive rates and improves diagnostic accuracy. The MoCA test provides information about general cognitive functioning disturbances that contribute to a diagnosis of HAND. The accuracy of MoCA for diagnosing HAND was reported at six cut-off points (scores 22–27). We assessed most studies as being applicable to the review question though we had concerns about the selection of participants in three studies. Recruitment period ranged from 2009 to 2015. Overall, 1014 patients were included but most studies recruited small samples. Eight cross-sectional studies met the inclusion criteria for meta-analysis. Quality assessment was performed according to the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) criteria. We extracted dichotomized positive and negative test results at various thresholds and calculated the sensitivity and specificity of MoCA. We conducted a systematic literature review, searching five databases from inception until January 2019. 💡 82% of providers who tested the toolkit said they plan to change their screening practices.This study aims to systematically review the evidence on the accuracy of the Montreal Cognitive Assessment (MoCA) test for diagnosing HIV–associated neurocognitive disorders (HAND) and to outline the quality and quantity of research evidence available about the accuracy of MoCA in populations infected with HIV. 💡 Patients aged 65 or older who were offered a cognitive screening during any type of primary care medical visit increased from 30% to 39%. 💡 Patients aged 65 or older who were offered a cognitive screening during a yearly wellness exam increased to 100%. Here are some of the key findings from the testing period: During the testing period, feedback was collected from providers to ensure the toolkit could be easily transferred and used in practice. 'The public launch comes after the toolkit was tested at select urban and rural clinics across the country earlier this year, which demonstrated an improvement in cognitive screening rates in a primary care setting. We are proud to have the MoCA Test included in a new toolkit sponsored by American Academy of Physician Associates, Cleveland Clinic, and Davos Alzheimer's Collaborative!